| Similar Articles |
|---|
 |
American Family Physician
September 15, 2000
Rosemarie Sweeney & Toni Lapp |
Newsletter Foundation Releases Data on Prescription Drug Trends... ISMP Pushing for Passage of Bills Dealing with Medical Errors... Officials Discuss Potential of Studying Agent Orange in Vietnam... WONCA Holds Rural Health Conference in Calgary... AMA's Tobacco Prevention Program Announces Expansion...   |
American Family Physician
August 1, 2000
Rosemarie Sweeney & Verna Rose |
Newsletter Private Industry, Academia Team Up on HIV Vaccine... AAFP Voices Support for Medicare Fee Increase... Cigars to Carry Health Warning Labels... States Lack Asthma Tracking System, Says CDC... The Ricky Ray Hemophilia Relief Fund Act Is Implemented... Clinton Orders Medicare to Cover Clinical Trials for Seniors... |
Pharmaceutical Executive
June 1, 2014
Ben Comer |
Take as Directed: From Force to Finesse in Promoting Adherence Healthcare players tout patient education and engagement as the keys to better drug adherence rates. Patients agree, as long as that translates to convenient and affordable access to therapy. |
Chemistry World
August 4, 2008
Pete Mitchell |
Vaccine failures shake up HIV research Prospects for an HIV vaccine have receded with the July decision by the US government National Institutes of Health (NIH) to cancel trials of its main vaccine candidate. |
Managed Care
February 2002
Joyce Ochs |
E-Prescribing Gets More Enticing Physicians today are writing prescriptions for patients on palm-held devices that seem eerily akin to medical practice on the Starship Enterprise... |
BusinessWeek
April 1, 2010
Bennett & Randall |
Will an AIDS Pill a Day Keep the Virus Away? Drugmaker Gilead is betting the one-pill PrEP treatment will slow the virus' spread - as are some of the world's top health agencies and philanthropists. |
CIO
September 26, 2013
Stephanie Overby |
Big Data Project Cuts Prescription Costs Express Scripts analytics portal helps doctors prescribe more cost-effective medicines. |
American Family Physician
July 15, 2006
Liz Smith |
Newsletter AMA Announces New Policies on DTC Advertising, Price Transparency... AAP Supports Recommendations of IOM Emergency Care Report... CDC Urges Awareness of Measles in Travelers to World Cup... etc. |
The Motley Fool
November 29, 2010
Brian Orelli |
Head to Head: Merck vs. Itself Merck's HIV drug doesn't work as well when taken once daily. |
American Family Physician
September 1, 2006
Gardiner & Dvorkin |
Promoting Medication Adherence in Children The problem of getting children to follow a treatment regimen is widespread and is frustrating for physicians. Having the child participate in devising the plan improves adherence. |
Insurance & Technology
September 16, 2005
Phil Britt |
Ounce of Prevention Horizon Blue Cross Blue Shield of New Jersey is providing system physicians with the ability to prescribe medicines electronically, which should improve safety and efficiency. |
Nursing
January 2011
Carl A. Kirton |
HIV: The Changing Epidemic Since its emergence in the early 1980s, HIV infection in the United States has evolved from an acute debilitating condition to a chronic, treatable illness. |
Pharmaceutical Executive
January 1, 2013
Al Topin |
The Doctor-Patient Disconnect Doctor-patient conversations aren't always what we think; this basic interaction represents both a problem and an opportunity for today's drug marketers, says the author. |
| AskMen.com |
Vaccine Helps Prevent HIV For the first time, an experimental vaccine has prevented infection with the AIDS virus, a watershed event in the deadly epidemic and a surprising result. |
American Family Physician
July 1, 2000 |
Letters to the Editor On whether physicians should be 'Bending the Rules to Get a Medication'... |
Chemistry World
December 3, 2014
Maria Burke |
Ebola vaccine passes first safety hurdle The vaccine was developed collaboratively by scientists at the NIH's National Institute of Allergy and Infectious Diseases, and at Okairos, a biotechnology company acquired by GlaxoSmithKline. |
Pharmaceutical Executive
March 1, 2011
Jerry Coamey |
Engage the Physician! New research shows that gauging the mind of the clinician is crucial to timely uptake of the new diagnostic tools offered by the genomic revolution |
Managed Care
May 2000 |
Physicians Fudge Insurance Forms To Help Patients A study confirms what has long been considered common but is rarely discussed: Physicians often lie about patients' conditions to gain or improve coverage for their treatment. |
Managed Care
April 2000
Tim Olsen |
Physician, Tarnish Not Thine Image Doctors who use the news media to criticize others, rather than initiate a constructive dialog about difficult issues such as antibiotic resistance, help erode the profession's influence. |
American Family Physician
July 1, 2000
Monica Preboth |
Clinical Briefs ISMP Warning on Heparin/Hespan Mix-ups... Increase in Vaccination Coverage Levels... Therapies for the Prevention of Breast Cancer... Online Service to Provide Hospital Statistics... Office Spirometry for the Detection of COPD... AAFP Annual Scientific Assembly... etc. |
BusinessWeek
January 29, 2007
Kerry Capell |
GlaxoSmithKline: Getting AIDS Drugs To More Sick People GlaxoSmithKline sells 90% of its vaccines, in volume terms, at not-for-profit prices to customers in the developing world. |
The Motley Fool
September 25, 2007
Brian Orelli |
Cold HIV Vaccine Gets Frozen Phase 2 clinical trials of Merck's HIV vaccine were frozen, leaving the door open for other drugmakers that have vaccines of their own in early trials. Investors, take note. |
American Family Physician
July 15, 2004
Joel E. Gallant |
HIV Counseling, Testing, and Referral By the year 2005, the CDC seeks to achieve the following: reduce annual new HIV infections from the current estimated 40,000 cases to 20,000 cases through the use of interventions such as counseling, HIV testing, and referral |
American Journal of Nursing
March 2010
David E. Vance |
Aging with HIV: Clinical Considerations for an Emerging Population Since the advent of highly active antiretroviral therapy, HIV infection has become a chronic, albeit life-threatening, condition that can be managed; therefore, more and more people are growing older with HIV. |
Bio-IT World
November 14, 2003
John Dodge |
Pfizer's Man with the R&D Plan As Pfizer senior vice president, science and technology, Peter B. Corr oversees $7.1 billion in annual research and development spending, the biggest private R&D budget in the world. In this interview, Corr talks about IT, clinical trials, and his $7-billion budget. |
Pharmaceutical Executive
August 1, 2011
Ted Prusik |
Cure for the Common Cold Chain Break An increasing number of pharmaceutical products prescribed in the US -- including insulin, vaccines, biologics, chemotherapeutic agents, blood products, and many antibiotics -- are temperature-sensitive. |
Managed Care
June 2001
Frank Diamond |
HMO/Physician Strain Creates Invisible Costs Perhaps goodwill is too much to ask for. However, peaceful coexistence can certainly help all players reach their mutual goal -- a smooth relationship that helps to get the job done... |
Managed Care
March 2005
William F. Jessee |
What Do Physicians Want From Health Plans? Standardizing health plan administrative processes and eliminating duplication of effort would go a long way toward strengthening the doctor-insurer relationship. |
American Family Physician
May 15, 2002
Alex H. Krist & Amy Crawford-Faucher |
Management of Newborns Exposed to Maternal HIV Infection The management of infants whose mothers are infected with the human immunodeficiency virus involves minimizing the risk of vertical transmission of HIV, recognizing neonatal HIV infection early, preventing opportunistic infections, and addressing psychosocial issues... |
BusinessWeek
April 26, 2004
Kerry Capell |
Vaccinating The World's Poor GlaxoSmithKline Biologicals is betting it can combat Third World scourges -- and still make money. |
Salon.com
July 17, 2000
Nina Teicholz |
When drugs take a holiday Could taking a break from protease inhibitors be the secret to treating AIDS? A new case of a 40-year-old man in Philadelphia shows it's possible. |
Chemistry World
January 19, 2015
Maria Burke |
Roadmap to fast track Ebola vaccine development A global group of experts has developed a 'roadmap' to help the health community fast track an Ebola vaccine. |
Chemistry World
September 26, 2007
Victoria Gill |
HIV Vaccines 'Will Not Work' Just days after US drug firm Merck revealed its leading HIV vaccine candidate had flopped in clinical trials, a leading immunologist has predicted that many other vaccines in the pipeline will also fail because their design is similarly flawed. |
American Journal of Nursing
March 2010
Bradley-Springer et al. |
Every Nurse Is an HIV Nurse The evolution of HIV infection into a chronic disease has implications across all clinical care settings. Every nurse should be knowledgeable about the disease in order to provide high-quality care to people with or at risk for HIV. |
BusinessWeek
September 2, 2010
Simeon Bennett |
David Margolis' Fight to End AIDS The North Carolina professor is relying on Zolinza, a rarely used Merck cancer drug, to stamp out AIDS. |
Scientific American
October 2008
John Rennie |
Hope and the Fight against HIV The battle must continue, even if 25 years of research have disappointed. |
Pharmaceutical Executive
July 3, 2007
Jill Wechsler |
Washington Report: Vaccines for Everyone New vaccines can be good business and a huge boon to public health. But the challenge is to establish prices that ensure global access, and to bring necessary medications to third-world countries. |
Pharmaceutical Executive
July 10, 2014
Fitzpatrick & Mohan |
Vaccines: Fire in the Cold Chain It's only recently that vaccine producers experienced the commercial returns commensurate with vaccines: long record of positive public health performance. |
Managed Care
October 2007 |
Data on Quality Lacking for Docs A new report says that insurers are better at providing quality information about hospitals than about physicians. |
American Family Physician
July 1, 2004
Lo Re & Gluckman |
Travel Immunizations The approach to vaccine recommendations should be based on a thorough assessment of the risks for travel-related diseases, the time available before trip departure, and current knowledge of the epidemiology of vaccine-preventable diseases. |
Pharmaceutical Executive
July 1, 2011
Cabacungan & Clark |
New Ways to Gain New Brand Insights If you can learn to understand patient and physician behavior, you are well on your way to strengthening the position of your product. |
American Family Physician
July 1, 2000
Rosemarie Sweeney & Toni Lapp |
Newsletter NRHA Names Rural Health Practitioner of the Year... Hotline Connecting Parents with Health Insurance for Children... U.S. Hospitals Receive Medication Safety Assessment Tool... One Half of Consumers Report Problems with Health Plans... Study Reports Medicaid Enrollment on the Rise... |
Pharmaceutical Executive
December 1, 2005
Alana Klein |
Thought Leader: A Q&A with Graham Allaway While researchers continue to hunt for new AIDS drugs, Graham Allaway, chief operating officer of Panacos Pharmaceuticals, is focusing on developing a treatment for patients failing therapy due to resistance. |
Managed Care
April 2002
Rhonda Greenapple |
HMOs Have Stake in Quelling Anger at Drug Store Counters Dissatisfied customers have a tendency to lash out and not be very discriminating about their targets. Prescription: Reduce the hassle... |
Chemistry World
February 9, 2007
Victoria Gill |
Africa's First Large-Scale HIV Vaccine Trial The first large-scale clinical trial of an HIV vaccine will involve around 3000 participants in five selected sites in South Africa. It will compare the effectiveness of the vaccine at reducing HIV infection compared to a placebo. |
Wired
January 2003
Richard Martin |
Testing the First AIDS Vaccine Medical establishment, government, and Genentech be damned -- Don Francis has never stopped believing. Now he's about to finish testing the first human AIDS vaccine. |
Pharmaceutical Executive
October 1, 2014
Jill Wechsler |
Ebola Crisis Challenges Pharma R&D Companies gain support and pressure to deliver new treatments for spreading outbreak. |
Chemistry World
January 6, 2011
Laura Howes |
Using HIV against itself US researchers have developed a 'Trojan horse' molecule that uses HIV to trigger the release of a drug that destroys the virus. |
Managed Care
August 2001 |
In Calif., Bonuses Based on Quality, Not Cost Savings Blue Cross of California has decided to move away from the traditional managed care incentive of rewarding physicians for controlling medical costs, and instead will implement a program in which physicians receive bonuses for quality of care and patient satisfaction... |
Chemistry World
October 23, 2014
Rebecca Trager |
US agency fast-tracks Ebola vaccine development The US Department of Health and Human Services is fast-tracking tests on an Ebola vaccine by providing $5.8 million under a one-year contract with the Maryland-based biotech company Profectus BioSciences |
